Small Extracellular Vesicles Derived from Cord Blood Plasma and Placental Mesenchymal Stem Cells Attenuate Acute Lung Injury Induced by Lipopolysaccharide (LPS)
Authors:
- Ranga P. ThiruvenkataramaniRTRanga P. Thiruvenkataramani
- Amal Abdul-HafezAAAmal Abdul-Hafez
- Tulasi KesarajuTKTulasi Kesaraju
- Hend MohamedHMHend Mohamed
- Sherif Abdelfattah IbrahimSherif Abdelfattah Ibrahim
- Amira OthmanAOAmira Othman
- Hattan ArifHAHattan Arif
- Ahmed A. ZareaAZAhmed A. Zarea
- Mohammed AbdulmageedMAMohammed Abdulmageed
- Myrna Gonzalez ArellanoMAMyrna Gonzalez Arellano
- Tarek MohamedTMTarek Mohamed
- Masamitsu KanadaMKMasamitsu Kanada
Open Access
- 25 December 2024
- journal article
- research article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (1) , 75
Abstract
Sepsis is a risk factor associated with increasing neonatal morbidity and mortality, acute lung injury, and chronic lung disease. While stem cell therapy has shown promise in alleviating acute lung injury, its effects are primarily exerted through paracrine mechanisms rather than local engraftment. Accumulating evidence suggests that these paracrine effects are mediated by mesenchymal stem cell (MSC)-derived small extracellular vesicles (sEVs), which play a critical role in immune system modulation and tissue regeneration. sEVs contain a diverse cargo of mRNA, miRNA, and proteins, contributing to their therapeutic potential. We hypothesize that sEVs derived from three distinct sources, cord blood plasma (CBP), Wharton jelly (WJ), and placental (PL) MSCs, may prevent the cytotoxicity induced by E. coli lipopolysaccharide (LPS) in lung alveolar epithelial cells. Objective: To determine the effects of CBP-, WJ-, and PL-MSCs-derived sEVs on cell viability, apoptosis, and proinflammatory cytokine production in alveolar epithelial cells and monocytes following LPS treatment. sEVs were collected from conditioned media of PL-MSCs, WJ-MSCs, and CBP using 50 nm membrane filters. sEVs were characterized based on nanoparticle tracking analysis (NTA), transmission electron microscopy (TEM), and Western blotting techniques. The protein concentration of isolated sEVs was used to standardize treatment doses. A549 cells and monocyte THP-1 cells were cultured and exposed to LPS in the presence or absence of sEVs for 72 h. Cell viability was measured using CellTiter-Glo 2.0 chemiluminescence-based assay. For cytokine analysis, A549 and THP-1 cells were pre-incubated for 24 h with or without PL- and CBP-sEVs, followed by exposure to LPS or control conditions for an additional 24 h. The conditioned media were collected, and interleukin-6 (IL-6) and interleukin-8 (IL-8) levels were quantified using ELISA. LPS treatment significantly reduced the viability of both A549 and THP-1 cells. The presence of CB- or WJ-sEVs significantly increased cell viability compared to controls. Cells treated with PL-sEVs showed increased cell viability but did not reach statistical significance. LPS-treated cells showed a significant increase in apoptosis and elevated levels of pro-inflammatory cytokines IL-6 and IL-8. All three sEVs types (CBP-, WJ-, and PL-sEVs) significantly reduced LPS-induced apoptosis and IL-6 release. Interestingly, while WJ-sEVs decreased IL-8, both CBP- and PL-sEVs led to an increase in IL-8 compared to their respective controls. CBP-, PL-, and WJ-derived sEVs demonstrated protective effects against LPS-induced injury in alveolar epithelial cells and monocytes, as evidenced by increased cell viability and modulation of pro-inflammatory cytokine release. These findings suggest that placenta-derived sEVs have the potential to modulate the immune response, mitigate inflammation, and prevent end-organ damage in neonatal sepsis.Keywords
Funding Information
- the Division of Neonatology, Department of Pediatrics and Human Development, College of Human Medicine, Michigan State university, East Lansing Michigan
- the graduate medical education (GME) at Sparrow hospital, Lansing, Michigan and the neonatology
- the government of Arab Republic of Egypt via the Egyptian cultural & Educational Bureau, Embassy of Egypt in Washington, DC, USA
This publication has 61 references indexed in Scilit:
- Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approachesJournal of Extracellular Vesicles, 2024
- Clinical Translation of Extracellular VesiclesAdvanced Healthcare Materials, 2023
- Exosomes from adipose-derived stem cells alleviate the inflammation and oxidative stress via regulating Nrf2/HO-1 axis in macrophagesFree Radical Biology and Medicine, 2021
- Exosomal miR-21 secreted by IL-1β-primed-mesenchymal stem cells induces macrophage M2 polarization and ameliorates sepsisLife Sciences, 2021
- Role of gingival mesenchymal stem cell exosomes in macrophage polarization under inflammatory conditionsInternational Immunopharmacology, 2020
- The senescence-associated secretory phenotype and its regulationCytokine, 2019
- Exosomal miR-146a Contributes to the Enhanced Therapeutic Efficacy of Interleukin-1β-Primed Mesenchymal Stem Cells Against SepsisStem Cells, 2017
- Bronchopulmonary dysplasia: The earliest and perhaps the longest lasting obstructive lung disease in humansEarly Human Development, 2013
- Emerging role of NF-κB signaling in the induction of senescence-associated secretory phenotype (SASP)Cellular Signalling, 2012
- Membrane vesicles, current state-of-the-art: emerging role of extracellular vesiclesCellular and Molecular Life Sciences, 2011